AU2003263895A8 - Contraceptive methods and formulations - Google Patents

Contraceptive methods and formulations

Info

Publication number
AU2003263895A8
AU2003263895A8 AU2003263895A AU2003263895A AU2003263895A8 AU 2003263895 A8 AU2003263895 A8 AU 2003263895A8 AU 2003263895 A AU2003263895 A AU 2003263895A AU 2003263895 A AU2003263895 A AU 2003263895A AU 2003263895 A8 AU2003263895 A8 AU 2003263895A8
Authority
AU
Australia
Prior art keywords
formulations
contraceptive methods
contraceptive
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU2003263895A
Other versions
AU2003263895A1 (en
Inventor
Craig R Travis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immugen Pharmaceuticals Inc
Original Assignee
Immugen Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immugen Pharmaceuticals Inc filed Critical Immugen Pharmaceuticals Inc
Publication of AU2003263895A8 publication Critical patent/AU2003263895A8/en
Publication of AU2003263895A1 publication Critical patent/AU2003263895A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
AU2003263895A 2002-08-16 2003-08-15 Contraceptive methods and formulations Abandoned AU2003263895A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40404002P 2002-08-16 2002-08-16
US60/404,040 2002-08-16
PCT/US2003/025826 WO2004016254A2 (en) 2002-08-16 2003-08-15 Contraceptive methods and formulations

Publications (2)

Publication Number Publication Date
AU2003263895A8 true AU2003263895A8 (en) 2004-03-03
AU2003263895A1 AU2003263895A1 (en) 2004-03-03

Family

ID=31888313

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003263895A Abandoned AU2003263895A1 (en) 2002-08-16 2003-08-15 Contraceptive methods and formulations

Country Status (2)

Country Link
AU (1) AU2003263895A1 (en)
WO (1) WO2004016254A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1644349B1 (en) 2003-06-24 2014-04-09 GW Pharma Limited Pharmaceutical compositions comprising cabbinochreme type compounds
EP2961402A4 (en) 2013-02-28 2016-11-23 Full Spectrum Lab Ltd Biosynthesis of cannabinoids
WO2016030828A1 (en) 2014-08-25 2016-03-03 Full Spectrum Laboratories Limited Apparatus and methods for the simultaneous production of cannabinoid compounds
US11033527B2 (en) 2018-02-07 2021-06-15 Immugen Pharma Llc Non-hormonal treatment of the genitourinary syndrome of menopause
EP4088723A4 (en) * 2020-01-08 2024-02-21 Chengdu Baiyu Pharmaceutical Co Ltd Cannabidiol derivative, and preparation method therefor and medical use thereof
EP4089084A4 (en) * 2020-01-08 2024-03-13 Chengdu Baiyu Pharmaceutical Co Ltd Cannabidiol derivative, and preparation method therefor and medical use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1053615A (en) * 1900-01-01
IL26902A (en) * 1965-12-07 1970-06-17 Commercial Solvents Corp Preparation for inhibiting spermiogenesis containing 6-(10'-hydroxy-undecyl)-2,4-dihydroxy-benzoic acid lactone

Also Published As

Publication number Publication date
WO2004016254A2 (en) 2004-02-26
WO2004016254A3 (en) 2004-04-15
AU2003263895A1 (en) 2004-03-03

Similar Documents

Publication Publication Date Title
HK1068555A1 (en) New formulations and use thereof
EP1423120A4 (en) 2h-phthalazin-1-ones and methods for use thereof
IL161255A0 (en) Gentle-acting skin-disinfectants and hydroalcoholic gel formulations
EP1539941A4 (en) Adzymes and uses thereof
GB0415630D0 (en) Sustained release ophthalmological device and method of making and using the same
AU2002357119A8 (en) Mitocidal compositions and methods
IL166424A0 (en) Sustained release formulations comprising lamotigine
AU2003287443A8 (en) Compositions and methods for pain reduction
AU2003279911A8 (en) Therapeutic formulations
IL163868A0 (en) Hermiasterlin derivatives and uses thereof
AU2003296369A8 (en) Imminoamines and preparation thereof
GB2395952B (en) Block copolymer and use thereof
EP1370240A4 (en) Neuroprotectants formulations and methods
IL165112A0 (en) Variant integrinpolypeptides and thereof
AU2003263895A8 (en) Contraceptive methods and formulations
EP1583557A4 (en) Vaccine compositions and methods
AU2003231827A8 (en) Pseudo-tissues and uses thereof
AU2003302173A8 (en) Spirotetrathiocarbamates and spirooxothiocarbamates
GB0214147D0 (en) Formulations
EP1471888A4 (en) Oral trimethobenzamide formulations and methods
GB0205826D0 (en) Therapeutic compositions and methods
EP1499338A4 (en) 7-hydroxy-16alpha-fluoro-5-androsten-17-ones and 7-hydroxy-16alpha-fluoro-5-androstan-17-ones and derivatives thereof
AU2003216442A8 (en) Enkurin and uses thereof
GB0223915D0 (en) Benzofuran derivatives formulations and uses thereof
GB0209377D0 (en) Oral formulations and uses

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase